Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
J Gynecol Oncol. 2022 Nov;33(6):e72. doi: 10.3802/jgo.2022.33.e72. Epub 2022 Aug 10.
This study aims to estimate the population-based incidence of gestational trophoblastic diseases (GTDs) and to identify the characteristics of gestational trophoblastic neoplasia (GTN) in Japan.
The annual number of GTD and live births from 1974 to 2018 were used to estimate the incidence of GTD. The data of 1,574 GTN cases from 1999 to 2018 were analyzed to identify the characteristics of low-risk GTN, high-risk GTN, placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT).
The incidence of hydatidiform mole was 2.02 per 1,000 live births on average which decreased from 1974 to 2008 and increased from 2009 to 2018. The incidence of low-risk GTN, high-risk GTN, PSTT, and ETT was 15.3, 3.5, 0.3, and 0.07 per 100,000 live births, respectively. The estimated incidence of post-molar GTN was 9.8% of molar patients. High-risk GTN was diagnosed more pathologically, had more various kinds of antecedent pregnancies, and had longer intervals after the antecedent pregnancy compared to low-risk GTN. Furthermore, 8.2% of high-risk GTN occurred after the subsequent non-molar pregnancy of hydatidiform mole. The cumulative percentage of developing high-risk GTN after hydatidiform mole reached 89.3% at the 60th month.
The incidence of hydatidiform mole, low-risk GTN, high-risk GTN was 2.02 per 1,000 live births, 15.3 per 100,000 live births, and 3.5 per 100,000 live births, respectively. High-risk GTN was diagnosed more pathologically and later after the antecedent pregnancy than low-risk GTN. Following molar patients for five years is needed to improve the mortality of malignant GTN.
本研究旨在估算日本妊娠滋养细胞疾病(GTD)的人群发病率,并确定妊娠滋养细胞肿瘤(GTN)的特征。
利用 1974 年至 2018 年的 GTD 年发病数和活产数来估算 GTD 的发病率。分析了 1999 年至 2018 年的 1574 例 GTN 病例数据,以确定低危 GTN、高危 GTN、胎盘部位滋养细胞肿瘤(PSTT)和上皮样滋养细胞肿瘤(ETT)的特征。
葡萄胎的平均发病率为 2.02/1000 活产,1974 年至 2008 年呈下降趋势,2009 年至 2018 年呈上升趋势。低危 GTN、高危 GTN、PSTT 和 ETT 的发病率分别为 15.3、3.5、0.3 和 0.07/100000 活产。葡萄胎后 GTN 的估计发病率为 9.8%的葡萄胎患者。高危 GTN 更多地通过病理诊断,具有更多种类型的前置妊娠,并且与低危 GTN 相比,前置妊娠后的间隔时间更长。此外,8.2%的高危 GTN 发生在葡萄胎后的非葡萄胎性非葡萄胎妊娠之后。葡萄胎后发展为高危 GTN 的累积百分比在第 60 个月达到 89.3%。
葡萄胎、低危 GTN、高危 GTN 的发病率分别为 2.02/1000 活产、15.3/100000 活产和 3.5/100000 活产。高危 GTN 的病理诊断和前置妊娠后诊断时间均晚于低危 GTN。需要对葡萄胎患者随访 5 年,以降低恶性 GTN 的死亡率。